These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 19389067

  • 1. Antifungal susceptibility profile in vitro of Sporothrix schenckii in two growth phases and by two methods: microdilution and E-test.
    Gutierrez-Galhardo MC, Zancopé-Oliveira RM, Monzón A, Rodriguez-Tudela JL, Cuenca-Estrella M.
    Mycoses; 2010 May; 53(3):227-31. PubMed ID: 19389067
    [Abstract] [Full Text] [Related]

  • 2. Sporothrix schenckii complex in Iran: Molecular identification and antifungal susceptibility.
    Mahmoudi S, Zaini F, Kordbacheh P, Safara M, Heidari M.
    Med Mycol; 2016 Aug 01; 54(6):593-9. PubMed ID: 26933207
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of itraconazole in combination with terbinafine against clinical strains of itraconazole-insensitive Sporothrix schenckii.
    Zhang X, Huang H, Feng P, Zhang J, Zhong Y, Xue R, Xie Z, Li M, Xi L.
    Eur J Dermatol; 2011 Aug 01; 21(4):573-6. PubMed ID: 21865116
    [Abstract] [Full Text] [Related]

  • 4. In vitro susceptibility of isolates of Sporothrix schenckii to amphotericin B, itraconazole, and terbinafine: comparison of yeast and mycelial forms.
    Kohler LM, Soares BM, de Assis Santos D, Da Silva Barros ME, Hamdan JS.
    Can J Microbiol; 2006 Sep 01; 52(9):843-7. PubMed ID: 17110976
    [Abstract] [Full Text] [Related]

  • 5. In vitro antifungal susceptibility of Sporothrix globosa isolates from Jilin Province, northeastern China: comparison of yeast and mycelial phases.
    Song Y, Li S, Shi Y, Zhao L, Cui Y, Yao L, Zhen Y, Chen R, Cui Y.
    Braz J Microbiol; 2021 Mar 01; 52(1):81-90. PubMed ID: 32557246
    [Abstract] [Full Text] [Related]

  • 6. Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine.
    Borba-Santos LP, Rodrigues AM, Gagini TB, Fernandes GF, Castro R, de Camargo ZP, Nucci M, Lopes-Bezerra LM, Ishida K, Rozental S.
    Med Mycol; 2015 Feb 01; 53(2):178-88. PubMed ID: 25394542
    [Abstract] [Full Text] [Related]

  • 7. Comparison of two in vitro antifungal sensitivity tests and monitoring during therapy of Sporothrix schenckii sensu stricto in Malaysian cats.
    Han HS, Kano R, Chen C, Noli C.
    Vet Dermatol; 2017 Feb 01; 28(1):156-e32. PubMed ID: 28133872
    [Abstract] [Full Text] [Related]

  • 8. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
    Cuenca-Estrella M, Arendrup MC, Chryssanthou E, Dannaoui E, Lass-Florl C, Sandven P, Velegraki A, Rodriguez-Tudela JL, AFST Subcommittee of EUCAST.
    Clin Microbiol Infect; 2007 Oct 01; 13(10):1018-22. PubMed ID: 17697001
    [Abstract] [Full Text] [Related]

  • 9. Molecular identification and susceptibility profile of Sporothrix schenckii sensu lato isolated in Argentina.
    Córdoba S, Isla G, Szusz W, Vivot W, Hevia A, Davel G, Canteros CE.
    Mycoses; 2018 Jul 01; 61(7):441-448. PubMed ID: 29500853
    [Abstract] [Full Text] [Related]

  • 10. In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
    Alvarado-Ramírez E, Torres-Rodríguez JM.
    Antimicrob Agents Chemother; 2007 Jul 01; 51(7):2420-3. PubMed ID: 17438048
    [Abstract] [Full Text] [Related]

  • 11. In vitro susceptibility of Sporothrix brasiliensis: Comparison of yeast and mycelial phases.
    Sanchotene KO, Brandolt TM, Klafke GB, Poester VR, Xavier MO.
    Med Mycol; 2017 Nov 01; 55(8):869-876. PubMed ID: 28472490
    [Abstract] [Full Text] [Related]

  • 12. In vitro inhibitory activity of sertraline against clinical isolates of Sporothrix schenckii.
    Villanueva-Lozano H, Treviño-Rangel RJ, Téllez-Marroquín R, Bonifaz A, Rojas OC, Hernández-Rodríguez PA, González GM.
    Rev Iberoam Micol; 2019 Nov 01; 36(3):139-141. PubMed ID: 31171430
    [Abstract] [Full Text] [Related]

  • 13. Genetic diversity and antifungal susceptibility profiles in causative agents of sporotrichosis.
    Rodrigues AM, de Hoog GS, de Cássia Pires D, Brihante RS, Sidrim JJ, Gadelha MF, Colombo AL, de Camargo ZP.
    BMC Infect Dis; 2014 Apr 23; 14():219. PubMed ID: 24755107
    [Abstract] [Full Text] [Related]

  • 14. In vitro susceptibility pattern of Sporothrix schenckii strains isolated from three centers in India.
    Ghosh A, Chakrabarti A, Hemashettar BM, Maiti PK.
    Indian J Med Res; 2001 Jun 23; 113():214-20. PubMed ID: 11816955
    [Abstract] [Full Text] [Related]

  • 15. In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases.
    Trilles L, Fernández-Torres B, Dos Santos Lazéra M, Wanke B, de Oliveira Schubach A, de Almeida Paes R, Inza I, Guarro J.
    Antimicrob Agents Chemother; 2005 Sep 23; 49(9):3952-4. PubMed ID: 16127080
    [Abstract] [Full Text] [Related]

  • 16. Canine sporotrichosis: polyphasic taxonomy and antifungal susceptibility profiles of Sporothrix species in an endemic area in Brazil.
    Boechat JS, Pereira SA, de Sá Machado AC, Viana PG, Almeida-Paes R, Zancopé-Oliveira RM, Gremião IDF, de Oliveira MME.
    Braz J Microbiol; 2021 Mar 23; 52(1):135-143. PubMed ID: 32617836
    [Abstract] [Full Text] [Related]

  • 17. Successful treatment of a disseminated Sporothrix schenckii infection and in vitro analysis for antifungal susceptibility testing.
    Kohler LM, Hamdan JS, Ferrari TC.
    Diagn Microbiol Infect Dis; 2007 May 23; 58(1):117-20. PubMed ID: 17498572
    [Abstract] [Full Text] [Related]

  • 18. In vitro susceptibility of antifungal drugs against Sporothrix brasiliensis recovered from cats with sporotrichosis in Brazil.
    Brilhante RS, Rodrigues AM, Sidrim JJ, Rocha MF, Pereira SA, Gremião ID, Schubach TM, de Camargo ZP.
    Med Mycol; 2016 Mar 23; 54(3):275-9. PubMed ID: 26591009
    [Abstract] [Full Text] [Related]

  • 19. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y, Akşit F, Kiraz N, Kiremitçi A.
    Mikrobiyol Bul; 2008 Jan 23; 42(1):149-55. PubMed ID: 18444574
    [Abstract] [Full Text] [Related]

  • 20. Feline sporotrichosis caused by Sporothrix schenckii sensu stricto in Southern Thailand: phenotypic characterization, molecular identification, and antifungal susceptibility.
    Indoung S, Chanchayanon B, Chaisut M, Buapeth KO, Morteh R, Jantrakajorn S.
    Med Mycol; 2022 Sep 30; 60(9):. PubMed ID: 36130102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.